Microglial Foxo3 shapes dopaminergic vulnerability in Parkinson disease
Baptiste Texier, Sarah Roudaud, Quentin Husson…·Marion Szelechowski
This study identifies Foxo3 as a key regulator of dopaminergic vulnerability through microglial mechanisms, showing that baseline microglial state, rather than acute transcriptional responses, determines neurodegeneration in Parkinson's disease.